Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do we find relevant parameters for in vitro cytotoxicity testing?

C A Reinhardt1

  • 1Cell Lab, Behavioral Biology, Federal Institute of Technology, ETH-Center, Zurich, Switzerland.

Molecular Toxicology
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preface.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Differentiation of embryonic chick brain cells in monolayer and reaggregate cultures: A potential model in vitro for neurotoxicity.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Introduction.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

In vitro predictive tests for eye irritants.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

The ECITTS integrated toxicity testing scheme: The application of in vitro test systems to the hazard assessment of chemicals.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Introduction.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same journal

Induction of a novel damage-specific DNA binding protein correlates with enhanced DNA repair in primate cells.

Molecular toxicology·1989
Same journal

Limitations of the fluorescent probe viability assay.

Molecular toxicology·1989
Same journal

Review: gene amplification--a cellular response to genotoxic stress.

Molecular toxicology·1989
Same journal

Xenobiotic regulation of glutathione S-transferase Ya gene expression.

Molecular toxicology·1989
Same journal

Meeting report: thirteenth annual interdisciplinary cancer research workshop.

Molecular toxicology·1989
Same journal

Plasmid-aided insertion of MMTV-LTR and ras DNAs to NIH 3T3 fibroblast cells makes them responsive to 2,3,7,8-TCDD causing overexpression of p21ras and down-regulation of EGF receptor.

Molecular toxicology·1989
See all related articles

Developing effective in vitro cytotoxicity tests requires an integrated approach, combining cell-based assays and structure-activity analyses to meet public demand for alternatives to animal testing.

Area of Science:

  • Toxicology
  • In vitro toxicology
  • Alternative testing methods

Background:

  • Current cytotoxicity test strategies are reviewed against the need for reliable in vitro alternatives to animal testing.
  • Public expectations for non-animal testing methods are high.
  • Existing in vitro and short-term mutagenicity tests highlight the limitations of a single 'supertest' approach.

Purpose of the Study:

  • To review the current strategy for designing cytotoxicity tests.
  • To discuss the relevance of various in vitro tests for topical and neurotoxicity assessment.
  • To propose an integrated approach for safety testing that aligns with public expectations and scientific rigor.

Main Methods:

  • Review of current cytotoxicity testing strategies.

Related Experiment Videos

  • Discussion of specific in vitro tests for topical and neurotoxicity.
  • Analysis of past experiences with in vitro mutagenicity testing.
  • Proposal for an integrated safety testing framework.

    • Main Results:

    • A single 'supertest' is insufficient for comprehensive safety assessment.
    • Various cytotoxicity tests have limitations when assessed in isolation.
    • An integrated approach is necessary to fulfill the goals of alternative testing.

    Conclusions:

    • Effective in vitro safety testing necessitates a combined strategy.
    • Integrating results from cell-based assays, structure-activity analyses, and kinetic/metabolic studies is crucial.
    • The relevance of integrated approaches should be evaluated based on the organisms potentially exposed.